NCT00592488View on ClinicalTrials.gov

Acetyl-L-Carnitine in the Treatment of Septic Shock

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

August 31, 2009

Study Completion Date

September 30, 2009

Conditions
Septic Shock
Interventions
DRUG

Acetyl-L-Carnitine

Acetyl-L-Carnitine - 4 g IV over 30 minutes, then 8 g iv over the next 12 hours

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University

OTHER

NCT00592488 - Acetyl-L-Carnitine in the Treatment of Septic Shock | Biotech Hunter | Biotech Hunter